Skip Nav Destination
1-6 of 6
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23
FO Smith, C Rauch, DE Williams, CJ March, D Arthur, J Hilden, BC Lampkin, JD Buckley, CV Buckley, WG Woods, PA Dinndorf, P Sorensen, J Kersey, D Hammond, ID Bernstein
Blood (1996) 87 (3): 1123–1133.
Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group
NA Heerema, DC Arthur, H Sather, V Albo, J Feusner, BJ Lange, PG Steinherz, P Zeltzer, D Hammond, GH Reaman
Blood (1994) 83 (8): 2274–2284.
Current status of the biology and treatment of acute non-lymphocytic leukemia in children (report from the ANLL strategy group of the Children's Cancer Study Group
BC Lampkin, W Woods, R Strauss, S Feig, G Higgins, I Bernstein, G D'Angio, R Chard, A Bleyer, D Hammond
Blood (1983) 61 (2): 215–228.
Immunologic evaluation in the prognosis of acute lymphoblastic leukemia. A report from Childrens Cancer Study Group
Blood (1981) 58 (3): 501–508.
Congenital hypoplastic anemia inhibition of erythropoiesis by sera from patients with congenital hypoplastic anemia
Blood (1975) 45 (1): 83–89.